These effects, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 assistance the notion of focusing on ACKR3 as a novel approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-related disorders. Disclaimer: The above mentioned https://derrickb061umb7.wikipresses.com/user